Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Arteaus Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Arteaus Therapeutics

Arteaus Therapeutics

Acquired

Arteaus Therapeutics, LLC: A US-based biotech firm specializing in developing migraine prevention therapies.

HQ
Cambridge, MA, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Arteaus Therapeutics, LLC is a US-based biotechnology firm dedicated to developing innovative therapies for migraine prevention. The company focuses on creating advanced biotechnological solutions to address the unmet needs of migraine sufferers, serving the pharmaceutical industry with cutting-edge therapeutic options.

Arteaus Therapeutics has made significant strides in the field of migraine therapy, contributing to advancements in preventive treatments. Their work has had a notable impact on the pharmaceutical industry, offering new hope and improved quality of life for individuals affected by chronic migraines.

Arteaus Therapeutics - Similar Companies

Arete Therapeutics logo

Arete Therapeutics

Aristea Therapeutics logo

Aristea Therapeutics

Artielle ImmunoTherapeutics logo

Artielle ImmunoTherapeutics

Arcuate Therapeutics logo

Arcuate Therapeutics

Artizan Biosciences logo

Artizan Biosciences

Artax Biopharma logo

Artax Biopharma

artaxbiopharma.com

Arthrosi Therapeutics logo

Arthrosi Therapeutics

arthrosi.com

Marlinspike Therapeutics logo

Marlinspike Therapeutics

Aria Pharmaceuticals logo

Aria Pharmaceuticals

Artin Bioscience logo

Artin Bioscience

artinbio.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Argentis Pharmaceuticals logo

Argentis Pharmaceuticals

argentisrx.com

Arbutus Biopharma logo

Arbutus Biopharma

arbutusbio.com

BioHealthonomics logo

BioHealthonomics

Areteia Therapeutics logo

Areteia Therapeutics

areteiatx.com

Arteaus Therapeutics - Quick Facts

Who are Arteaus Therapeutics' competitors?

Companies similar to Arteaus Therapeutics include Arete Therapeutics, Aristea Therapeutics, Artielle ImmunoTherapeutics and Arcuate Therapeutics.

When was Arteaus Therapeutics founded?

Arteaus Therapeutics was founded in 2011.

Where is Arteaus Therapeutics' headquarters located?

Arteaus Therapeutics' headquarters is located in Cambridge, MA, US.

When was Arteaus Therapeutics' last funding round?

Arteaus Therapeutics' most recent funding round was for $12M (USD) in July 2012.

How much has Arteaus Therapeutics raised to-date?

As of Jul 25, 2012, Arteaus Therapeutics has raised a total of $30M (USD).

Arteaus Therapeutics - Classification

Ownership
  • Venture Capital
Geographic Exposure
  • United States
Revenue
  • Recurring
Main Product
  • Biotech
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 21 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 517111Wired Telecommunications Carriers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 517000Telecommunications
  • 623000Nursing and Residential Care Facilities
  • 517100Wired and Wireless Telecommunications (except Satellite)
  • 325410Pharmaceutical and Medicine Manufacturing
  • 517110Wired and Wireless Telecommunications Carriers (except Satellite)
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4810Telephone Communications
  • 4813Telephone Communications, Except Radiotelephone
  • 2800Chemicals And Allied Products
  • 4800Communications
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified